Regenxbio (RGNX) Non Operating Income (2016 - 2025)
Historic Non Operating Income for Regenxbio (RGNX) over the last 12 years, with Q3 2025 value amounting to -$9.5 million.
- Regenxbio's Non Operating Income fell 48411.93% to -$9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$23.0 million, marking a year-over-year decrease of 43196.13%. This contributed to the annual value of $6.2 million for FY2024, which is 3931.28% up from last year.
- Per Regenxbio's latest filing, its Non Operating Income stood at -$9.5 million for Q3 2025, which was down 48411.93% from -$7.6 million recorded in Q2 2025.
- In the past 5 years, Regenxbio's Non Operating Income registered a high of $3.1 million during Q3 2023, and its lowest value of -$9.5 million during Q3 2025.
- In the last 5 years, Regenxbio's Non Operating Income had a median value of -$2.2 million in 2022 and averaged -$2.6 million.
- Its Non Operating Income has fluctuated over the past 5 years, first skyrocketed by 20269.75% in 2024, then tumbled by 123395.87% in 2025.
- Quarter analysis of 5 years shows Regenxbio's Non Operating Income stood at -$6.2 million in 2021, then surged by 64.23% to -$2.2 million in 2022, then skyrocketed by 139.06% to $862000.0 in 2023, then plummeted by 78.89% to $182000.0 in 2024, then crashed by 5336.26% to -$9.5 million in 2025.
- Its last three reported values are -$9.5 million in Q3 2025, -$7.6 million for Q2 2025, and -$6.0 million during Q1 2025.